Cerebrovascular and genetic disorders
Cerebrovascular and genetic disorders is a research topic within Neurology. Science Explorer counts 7.7k research works in it since 1950. 13.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a hereditary small vessel disease. It explores the genetics, clinical manifestations, diagnostic strategies, pathogenesis, and management aspects of CADASIL, with a particular emphasis on Notch3 receptor mutations, cerebrovascular dysfunction, white matter lesions, and cognitive impairment.
- CADASIL
- Notch3 receptor
- small vessel disease
- HtrA1 mutations
- cerebrovascular dysfunction
- white matter lesions
- genetic model
- MRI hyperintensities
- cognitive impairment
- microbleeds
- Research works
- 7.7k fractional, since 1950
- In the world top 10%
- 1k per year above
- Top-10% rate
- 13.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cerebrovascular and genetic disorders research?
By volume, the United States and China publish the most (304 and 246 works in 2022–2025).
By volume, 2022–2025
- 1 United States 304 works
- 2 China 246 works
- 3 France 84 works
- 4 Japan 76 works
- 5 United Kingdom 64 works
- 6 Germany 58 works
- 7 India 53 works
- 8 Italy 51 works
- 9 South Korea 45 works
- 10 Canada 31 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cerebrovascular and genetic disorders research?
By volume in 2022–2025, Inserm publishes the most Cerebrovascular and genetic disorders research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Capital Medical University.
By volume, 2022–2025
- 1 InsermFrance 8 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 7 works
- 3 Capital Medical UniversityChina 7 works
- 4 Peking Union Medical College HospitalChina 7 works
- 5 University of California, San FranciscoUnited States 6 works
- 6 All India Institute of Medical SciencesIndia 5 works
- 7 University College LondonUnited Kingdom 5 works
- 8 Mayo Clinic in ArizonaUnited States 5 works
- 9 National Cerebral and Cardiovascular CenterJapan 5 works
- 10 WinnMedUnited States 5 works
Where is Cerebrovascular and genetic disorders research done?
The largest centres of Cerebrovascular and genetic disorders research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Paris.
Largest cities, 2022–2025
Where it is the local speciality
- ParisFR · 40.0 works3.4×
Location quotient: how much more of its research is in Cerebrovascular and genetic disorders than the world average.
Is Cerebrovascular and genetic disorders research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cerebrovascular and genetic disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.